[HTML][HTML] Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK

M Khalil, HW Zafar, V Quarshie, F Ahmed - The Journal of Headache and …, 2014 - Springer
Background Chronic migraine affects 2% of the population. It results in substantial disability
and reduced quality of life. Medications used for prophylaxis in episodic migraine may also …

[HTML][HTML] OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients

HT Wong, M Khalil, F Ahmed - The journal of headache and pain, 2020 - Springer
Objective To report the pregnancy outcomes on patients with chronic migraine exposed to
onabotulinumtoxinA from Hull Headache Clinic. Background Migraines are common in …

Managing cluster headache

DY Wei, M Khalil, PJ Goadsby - Practical Neurology, 2019 - pn.bmj.com
Cluster headache is a neurological disorder that presents with unilateral severe headache
associated with ipsilateral cranial autonomic symptoms. Cluster headache attacks often …

[HTML][HTML] Chronic daily headaches

F Ahmed, R Parthasarathy, M Khalil - Annals of Indian Academy of …, 2012 - journals.lww.com
Abstract Chronic Daily Headache is a descriptive term that includes disorders with
headaches on more days than not and affects 4% of the general population. The condition …

[HTML][HTML] Does analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuse

F Ahmed, HW Zafar, A Buture, M Khalil - Springerplus, 2015 - Springer
Chronic migraine affects 2% of the population and has substantial impact on quality of life
and considerable burden on healthcare resources. 50–80% patients with chronic migraine …

Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence

M Khalil, D Moreno‐Ajona… - European Journal of …, 2022 - Wiley Online Library
Background and purpose Chronic migraine is a highly disabling primary headache disorder
that is the most common diagnosis of patients seen at tertiary headache centres. Typical oral …

Hemicrania continua responsive to botulinum toxin type a: a case report

M Khalil, F Ahmed - Headache: The Journal of Head and Face …, 2013 - Wiley Online Library
Background Hemicrania continua (HC) is a primary headache disorder with full response to
indomethacin as one of its diagnostic criteria; however, indomethacin's side effects could …

Long term outcome for onabotulinumtoxinA (Botox) therapy in chronic migraine: a 2-year prospective follow-up audit of patients attending the Hull (UK) migraine clinic

F Ahmed, A Buture, T Tanvir, M Khalil - Cephalalgia Reports, 2021 - journals.sagepub.com
Objective: The objective of this prospective audit was to determine the long term outcome of
patients diagnosed with chronic migraine who were treated with onabotulinumtoxinA for the …

How to do it: bedside ultrasound to assist lumbar puncture

S Williams, M Khalil, A Weerasinghe, A Sharma… - Practical …, 2017 - pn.bmj.com
For many neurologists, lumbar puncture is the only practical procedure that they undertake
on a regular basis. Although anaesthetists and emergency physicians routinely employ …

Iatrogenic visual aura: a case report and a brief review of the literature

A Buture, M Khalil, F Ahmed - Therapeutics and Clinical Risk …, 2017 - Taylor & Francis
Iatrogenic migraine aura following transseptal catheterization has only rarely been reported
in the literature. We report the case of a 60-year-old female who presented with new onset of …